Drug Trial Radar · NCT05214768
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Mar 4, 2022
Primary completion
Jul 2, 2024
Study completion Aug 22, 2025
Sponsor
- Lead sponsor
- CelgeneBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jan 31, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.
Conditions
- Eosinophilic Gastroenteritis
Interventions
CC-93538Drug
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean Number of Peak Eosinophils (Eos) Count Per High-power Field (Hpf) in Gastrointestinal (GI) BiopsiesTime frame: Baseline and Week 16
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Local Institution - 010
Akita, Japan
Local Institution - 017
Hirosaki, Japan
Local Institution - 015
Hiroshima, Japan
Local Institution - 020
Kitakyushu, Japan
Local Institution - 004
Kobe, Japan
Local Institution - 011
Maebashi, Japan
Local Institution - 013
Nagaoka, Japan
Local Institution - 006
Nagoya, Japan
Local Institution - 021
Nagoya, Japan
Local Institution - 008
Niigata, Japan
Local Institution - 012
Ōgaki, Japan
Local Institution - 005
Shibukawa, Japan
Local Institution - 019
Tokyo, Japan
Local Institution - 003
Yamagata, Japan
Local Institution - 024
Gifu, Gifu, Japan
Local Institution - 022
Himeji-shi, Hyōgo, Japan
Local Institution - 009
Nishinomiya, Hyōgo, Japan
Local Institution - 018
Kagoshima, Kagoshima-ken, Japan
Local Institution - 0025
Tsu, Mie-ken, Japan
Local Institution - 025
Tsu, Mie-ken, Japan
Local Institution - 023
Sendai, Miyagi, Japan
Local Institution - 016
Nagasaki, Nagasaki, Japan
Local Institution - 002
Osaka, Osaka, Japan
Local Institution - 007
Bunkyo-ku, Tokyo, Japan
Local Institution - 001
Setagaya-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.